Company: Paradigm Capital
Job title: Analyst, Healthcare & Biotechnology
Scott McAuley is an Equity Research Analyst at Paradigm Capital, an independent Canadian investment bank. His coverage includes a wide range of drug development, medical device, and specialty pharma companies across numerous therapeutic areas and underlying technologies. He sees healthcare as an exciting and tangled web connecting scientists, patients, physicians, payers, regulators, and society at large, and believes that success relies on navigating these diverse interests.
Prior to Paradigm, he worked with the Impact Centre, an incubator at the University of Toronto, helping students and faculty across engineering and medicine commercialize their research. He holds a PhD in Biochemistry from the University of Toronto, a M.Sc. in Chemistry from the University of Toronto and a B.Sc. in Chemistry from McGill University.
Panel Discussion: Dispelling Common Misconceptions About Biotech Funding and Applying this Understanding to Cannabinoid Pharmaceuticals 12:20 pm
day: Day Two